Biological properties of purified recombinant HCV particles with an epitope-tagged envelope

Biochemical and Biophysical Research Communications

Volumn 395, Issue 4, 2010, Pages 565-571

  Takahashi, Hitoshi ^a,b   Akazawa, Daisuke ^a,b   Kato, Takanobu ^a   Date, Tomoko ^a   Shirakura, Masayuki ^a,b   Nakamura, Noriko ^b   Mochizuki, Hidenori ^b   Tanaka Kaneko, Keiko ^a   Sata, Tetsutaro ^a   Tanaka, Yasuhito ^c   Mizokami, Masashi ^d   Suzuki, Tetsuro ^a   Wakita, Takaji ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d National Center for Global Health and Medicine   (Japan)

Author keywords

Envelope protein; Hepatitis C virus; Particle; Purification; Vaccine

Indexed keywords

EPITOPE; PROTEIN E2N151K; PROTEIN J6; PROTEIR JFH 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; CELL STRAIN; CHIMERA; CULTURE MEDIUM; ELECTRON MICROSCOPY; EXPRESSED SEQUENCE TAG; GENE MUTATION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE TAGGED SITE; STAINING; STRUCTURE ANALYSIS; ULTRAFILTRATION; VIRUS CULTURE; VIRUS PURIFICATION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; EPITOPES; GLYCOSYLATION; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; VIRAL HEPATITIS VACCINES; VIRION;

HEPATITIS C VIRUS; MUS;

EID: 77952103879     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.081     Document Type: Article

References (16)

1. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology 38 (1995) 162-169
2. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., and Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88 (1991) 2451-2455
3. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., and Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87 (1990) 9524-9528
4. Stamataki Z., Coates S., Evans M.J., Wininger M., Crawford K., Dong C., Fong Y.L., Chien D., Abrignani S., Balfe P., Rice C.M., McKeating J.A., and Houghton M. Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 25 (2007) 7773-7784
5. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., and Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125 (2003) 1808-1817
6. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
7. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102 (2005) 9294-9299
8. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
9. Aizaki H., Morikawa K., Fukasawa M., Hara H., Inoue Y., Tani H., Saito K., Nishijima M., Hanada K., Matsuura Y., Lai M.M., Miyamura T., Wakita T., and Suzuki T. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82 (2008) 5715-5724
10. van den Hoff M.J., Moorman A.F., and Lamers W.H. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res. 20 (1992) 2902
11. Takeuchi T., Katsume A., Tanaka T., Abe A., Inoue K., Tsukiyama-Kohara K., Kawaguchi R., Tanaka S., and Kohara M. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology 116 (1999) 636-642
12. Delgrange D., Pillez A., Castelain S., Cocquerel L., Rouille Y., Dubuisson J., Wakita T., Duverlie G., and Wychowski C. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J. Gen. Virol. 88 (2007) 2495-2503
13. Akazawa D., Date T., Morikawa K., Murayama A., Omi N., Takahashi H., Nakamura N., Ishii K., Suzuki T., Mizokami M., Mochizuki H., and Wakita T. Characterization of infectious hepatitis C virus from liver-derived cell lines. Biochem. Biophys. Res. Commun. 377 (2008) 747-751
14. Miyanari Y., Atsuzawa K., Usuda N., Watashi K., Hishiki T., Zayas M., Bartenschlager R., Wakita T., Hijikata M., and Shimotohno K. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell Biol. 9 (2007) 1089-1097
15. Nielsen S.U., Bassendine M.F., Burt A.D., Martin C., Pumeechockchai W., and Toms G.L. Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 80 (2006) 2418-2428
16. Kaito M., Watanabe S., Tanaka H., Fujita N., Konishi M., Iwasa M., Kobayashi Y., Gabazza E.C., Adachi Y., Tsukiyama-Kohara K., and Kohara M. Morphological identification of hepatitis C virus E1 and E2 envelope glycoproteins on the virion surface using immunogold electron microscopy. Int. J. Mol. Med. 18 (2006) 673-678